| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30071911 | HIV | ENSG00000136807.14 | protein_coding | CDK9 | No | No | 1025 | P50750 |
| TVIS30071912 | HIV | ENSG00000136807.14 | protein_coding | CDK9 | No | No | 1025 | P50750 |
| TVIS44031380 | HTLV-1 | ENSG00000136807.14 | protein_coding | CDK9 | No | No | 1025 | P50750 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CDK9 |
|---|---|
| DrugBank ID | DB15442 |
| Drug Name | Trilaciclib |
| Target ID | BE0002207 |
| UniProt ID | P50750 |
| Regulation Type | inhibitor |
| PubMed IDs | 26826116 |
| Citations | Bisi JE, Sorrentino JA, Roberts PJ, Tavares FX, Strum JC: Preclinical Characterization of G1T28: A Novel CDK4/6 Inhibitor for Reduction of Chemotherapy-Induced Myelosuppression. Mol Cancer Ther. 2016 May;15(5):783-93. doi: 10.1158/1535-7163.MCT-15-0775. Epub 2016 Jan 29. |
| Groups | Approved; Investigational |
| Direct Classification | |
| SMILES | CN1CCN(CC1)C1=CN=C(NC2=NC3=C(C=C4N3C3(CCCCC3)CNC4=O)C=N2)C=C1 |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL3894860 |
